free@rss.ponder.catMB to

Ars Technica - Science@rss.ponder.catEnglish · 2 months ago

More bad news for psychedelic drug company: FDA expands probe after rejection

arstechnica.com

0

8

More bad news for psychedelic drug company: FDA expands probe after rejection

arstechnica.com

free@rss.ponder.catMB to

Ars Technica - Science@rss.ponder.catEnglish · 2 months ago

0

Psychedelic drug company Lykos already slashed staff and overhauled leadership.

You must log in or register to comment.

Chat

Ars Technica - Science@rss.ponder.cat

arstechnica_science@rss.ponder.cat

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: [email protected]

Community locked: only moderators can create posts. You can still comment on posts.

Serving the Technologist for more than a decade. IT news, reviews, and analysis.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

1 user / day
14 users / week
313 users / month
526 users / 6 months
1 local subscriber
40 subscribers
122 Posts
65 Comments
Modlog